Clinical trial
Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT
NCT05146245 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT
- Lead sponsor
- Erasmus Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 1, 2021
- Completion date
- May 31, 2024
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.